HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients.

Abstract
We aimed to determine if successful or failed eradication of Helicobacter pylori with triple therapy causes any difference in gastric mucosal histology. Japanese H. pylori-positive patients with a healed peptic ulcer received high (n = 112) or low (n = 113) doses of triple therapy (omeprazole, amoxicillin and clarithromycin) for 1 week. Biopsies from the greater curvature of the central antrum and upper corpus were taken 6 weeks and 30 weeks after treatment completion, and gastric mucosal histology compared between successful (n = 171) and failed (n = 34) eradication groups. Morphological variables of gastritis were graded according to the updated Sydney System. Successful eradication therapy was defined as improvement in inflammation, neutrophil activity and atrophy; failed eradication therapy as improvement in inflammation and neutrophil activity only. Gastric mucosal atrophy gradually improved (in addition to improvements in inflammation and neutrophil activity) with successful eradication of H. pylori infection.
AuthorsH Watanabe, N Yamaguchi, H Kuwayama, C Sekine, N Uemura, M Kaise, T Nakamura, M Kubo, S Yoshida, K Haruma, M Inoue, T Shimatani, E Sanuki, H Mieno, M Kawanishi, S Nakazawa, T Tanaka
JournalThe Journal of international medical research (J Int Med Res) 2003 Sep-Oct Vol. 31 Issue 5 Pg. 362-9 ISSN: 0300-0605 [Print] England
PMID14587302 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Amoxicillin
  • Clarithromycin
  • Omeprazole
Topics
  • Aged
  • Amoxicillin (administration & dosage)
  • Anti-Bacterial Agents (administration & dosage)
  • Anti-Ulcer Agents (administration & dosage)
  • Biopsy
  • Clarithromycin (administration & dosage)
  • Drug Therapy, Combination
  • Female
  • Gastric Mucosa (microbiology)
  • Helicobacter pylori (metabolism)
  • Humans
  • Inflammation
  • Japan
  • Male
  • Middle Aged
  • Omeprazole (administration & dosage)
  • Peptic Ulcer (microbiology, therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: